Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

Filing date Description Form Filing Group Filer View

An amendment to the SC 13G filing

SC 13G/A
Other
0000902664-20-001118.pdf 0000902664-20-001118.rtf 0000902664-20-001118.xls View HTML

A statement of beneficial ownership of common stock by certain persons

SC 13G
Other
0001104659-20-021213.pdf 0001104659-20-021213.rtf 0001104659-20-021213.xls View HTML

An amendment to the SC 13G filing

SC 13G/A
Other
0000935836-20-000109.pdf 0000935836-20-000109.rtf 0000935836-20-000109.xls View HTML

A statement of beneficial ownership of common stock by certain persons

SC 13G
Other
0000834237-20-008014.pdf 0000834237-20-008014.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Vollins James 0001103021-20-000025.pdf 0001103021-20-000025.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0001103021-20-000026.pdf 0001103021-20-000026.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Cukier Herm 0001103021-20-000028.pdf 0001103021-20-000028.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Plesha Scott M. 0001103021-20-000030.pdf 0001103021-20-000030.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Smith Thomas B 0001103021-20-000032.pdf 0001103021-20-000032.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Smith Thomas B 0001103021-20-000018.pdf 0001103021-20-000018.rtf View HTML

Data provided by Kaleidoscope.

BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon